Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

06/08/04 A phase II trial of conventional radiation therapy (XRT) plus high dose tamoxifen (TAM) for the treatment of supratentorial glioblastoma multiforme (GBM): RTOG protocol BR-0021.        

06/08/04 A phase II trial of erlotinib (OSI-774) in patients (pts) with recurrent malignant gliomas (MG) not on EIAEDs.        

06/08/04 A phase II trial of LY317615 in patients with recurrent high grade gliomas.        

06/08/04 Adjuvant chemotherapy with temozolomide and pegylated liposomal doxorubicin in the first-line therapy of patients with glioblastoma ¨C a phase-II trial.        

06/08/04 An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: Initial report of RTOG 94-02.        

06/08/04 Baseline pathological and radiological assessment of tumor angiogenesis predicts survival in patients with oligodendrogliomas.        

06/08/04 Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.        

06/08/04 Combination chemotherapy with gemcitabine and docetaxel for recurrent germ cell tumors in the central nervous system.        

06/08/04 Combined administration of imatinib mesylate and ionizing radiation leads to increased radiosensitivity in the human glioblastoma cell line RuSi RS1.        

06/08/04 Concordance of FDG-PET scan and MRI- spectroscopy in primary and metastatic intracranial tumors.        

06/08/04 Efficacy of platinum-based chemotherapy after cranial irradiation in patients with brain metastasis from non-small cell lung cancer.        

06/08/04 High failure rate in spinal ependymomas with long-term follow-up.        

06/08/04 High-dose (HD) irinotecan in patients with recurrent unresectable high-grade gliomas on glucoronidation-enhancing anticonvulsants (GEACs): A phase I/II study.        

06/08/04 How costly is brain cancer? Healthcare services use and costs from across the US.        

06/08/04 Imatinib (STI 571) is active in patients (PTS) with high-grade gliomas progressing on standard therapy.        

06/08/04 Imatinib (STI571) plus hydroxyurea: Safety and efficacy in pre-treated, progressive glioblastoma multiforme (GBM) patients (pts).        

06/08/04 Intensity modulated radiotherapy in high grade gliomas: Clinical and dosimetric results.        

06/08/04 Intraventricular application of rituximab as a treatment option in patients with CNS lymphoma and leptomeningeal disease.        

06/08/04 Microvessel density predicts behavior in pediatric optic pathway/hypothalamic gliomas.        

---

Displaying Stories 5330 to 5349 of 7812
Previous 20           Next 20